Key search terms included “Type 2 Diabetes,” “Digital Diabetes Management,” “Mobile Health,” “Telemedicine,” “Remote Monitoring,” “Continuous Glucose Monitoring (CGM),” “Smart Insulin Pens,” “Artificial Intelligence in Diabetes,” “Blood Glucose Control,” and “HbA1c Reduction.” The search was limited to English-language studies published between January 1, 2020, and January 01, 2025, to ensure the inclusion of the most recent advancements in DDMTs. The gene discussed is INS; the disease is diabetes mellitus.